Latest Breaking News On - Denali therapeutic - Page 1 : comparemela.com

FY2028 EPS Estimates for Denali Therapeutics Inc Cut by Analyst (NASDAQ:DNLI)

FY2028 EPS Estimates for Denali Therapeutics Inc Cut by Analyst (NASDAQ:DNLI)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesNew zealand generalNew zealandStifel nicolausVickil satoBryanj wattsEventide asset managementSecurities exchange commissionGoldman sachs groupGotham asset managementCapital partnersDenali therapeutics incWellington management groupDenali therapeutics company profileDenali therapeuticsFree report

Research Analysts Offer Predictions for Denali Therapeutics Inc s Q3 2024 Earnings (NASDAQ:DNLI)

Research Analysts Offer Predictions for Denali Therapeutics Inc s Q3 2024 Earnings (NASDAQ:DNLI)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Vickil satoJpmorgan chase coDimensional fund advisorsSecurities exchange commissionDenali therapeutics incMetlife investment managementBlackrock incDenali therapeuticsFree reportDenali therapeuticGet free reportTherapeutics trading downLife investment managementFund advisorsDirector vickiExchange commission

Denali Therapeutics Inc Forecasted to Post Q3 2024 Earnings of ($0 58) Per Share (NASDAQ:DNLI)

Denali Therapeutics Inc Forecasted to Post Q3 2024 Earnings of ($0 58) Per Share (NASDAQ:DNLI)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesBryanj wattsVickil satoDenali therapeutics incDenali therapeutics company profileVirtu financialJpmorgan chase coPier capitalSecurities exchange commissionDenali therapeuticsFree reportDenali therapeuticTherapeutics stock downGet free reportRetirement systemDirector vicki

Denali Therapeutics (NASDAQ:DNLI) vs Turnstone Biologics (NASDAQ:TSBX) Critical Comparison

Denali Therapeutics (NASDAQ:DNLI) vs Turnstone Biologics (NASDAQ:TSBX) Critical Comparison
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesSouth san franciscoTurnstone biologics corpBiogen ma incGenzyme corporationTakeda pharmaceutical companyPharma incGenentech incDenali therapeutics incBiogen international gmbTurnstone biologicsGet free reportDenali therapeuticsDenali therapeuticGiven turnstone biologicBiologics corp

US Neurologists Emphasize Tremendous Unmet Treatment Need

Gene therapies and LRRK2 inhibition are at the forefront of prescribers interest, highlighting the need for a truly disease modifying therapy..

United statesAnnovis bioAddex pharmaSpherix networkSpherix global insight market dynamixDenali therapeuticCerevel therapeuticSun pharma advanceGlobal insightsSpherix global insightsSpherix global insightArkinson 39s diseaseEnali theraputicsSun pharmaAnnovis bioAddex pharma